LAUSR

Adenotonsillectomy (AT) is one of the most common surgical procedures performed in children internationally. Historically, it was used to treat children with chronic tonsillitis; however, today most children presenting for AT have sleep-disordered breathing and obstructive sleep apnea syndrome (OSAS) caused by tonsillar hypertrophy. Perioperative respiratory adverse events (PRAEs) are common complications after AT, and an increase in childhood obesity is associated with an increase in the incidence of upper airway obstruction and sleep-disordered breathing, further complicating perioperative medication management. clinical in children AT to compare the incidence of PRAEs after intranasal of midazolam, a incidence of PRAEs in the midazolam group (56.5%) compared with both the dexmedetomidine (24.2%) and saline control (40.8%) groups. 1 No significant differences observed between the groups at the time of induction of